EP#49: Evangelos Evangelou, Co-Founder & CSO of OpenDNA

Published on January 11, 2023

On this episode, we welcome Dr Evangelou, the co-founder and CSO of OpenDNA.

OpenDNA has developed a cloud-based genomic precision medicine platform bound to change our lives!

By using AI to analyze each patient’s specific genetic and clinical data, this groundbreaking platform can predict if a person is at risk of developing cardiometabolic syndrome, enabling physicians to offer effective Personalized treatments to patients.

Future Goals?

To apply the technology to other complex polygenic disease states such as cancer, osteoporosis and autoimmune diseases.

ℹ Dr Evangelou is the co-founder and CSO of OpenDNA. He is a Professor of Clinical and Molecular Epidemiology at the University of Ioannina Medical School, GR and he holds a joint affiliation with Imperial College London, UK. He has been trained in Epidemiology and Biostatistics, and he works with genomics big data in order to decipher the genetic architecture of complex diseases

Timestamps

    00:00 Intro

    02:02 The potential of building a startup ecosystem in Ioannina

    04:08 Background

    05:41 Birth of the idea and the decision towards entrepreneurship

    08:19 Tips on launching a company abroad

    09:25 From the idea to the creation of OpenDNA

    14:07 Who is the customer

    15:45 Handling the ethical issues related to data collection

    16:49 How big is the market?

    18:51 The unique competitive advantage

    20:10 What type of solution are you providing?

    20:41 What is the customer pipeline for the next months?

    21:53 Will Europe also proceed to adopt these types of solutions?

    23:24 Fundraising, the Incubator In Israel

    24:59 The growth of the team, the lab in Ioannina

    26:14 The team

    28:20 The exit strategy

    29:23 The vision

Stay up-to-date with exclusive content.

Subscribe to our FREE newsletter and receive valuable content every month.